Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NRP2 antisense RNA 1 (NRP2-AS1)
- Target
- NRP2-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
NRP2 antisense RNA 1 (NRP2-AS1) is a long non-coding antisense RNA highly induced in human macrophages during inflammation, potentially regulating cytokine and inflammatory gene expression by interacting with NF-κB pathways, but it is not currently established as a therapeutic target or associated with approved drugs or biomarkers.
- Other names
- hLinfRNA2human Long-noncoding inflammation associated RNA 2
02
Biological functions
Regulation of gene expressionInflammation regulationImmune response
03
Disease associations
InflammationOther (possible role in metabolic disease)
Beyond the preview
Go deeper on NRP2 antisense RNA 1 (NRP2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NRP2 antisense RNA 1 (NRP2-AS1).